Analysts expect BioNTech to report an earnings per share (EPS) of $0.75. Investors in BioNTech are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive ...
8d
BioNTech (BNTX): Assessing Valuation as Investor Sentiment Shifts After Recent Pipeline Developments
BioNTech (BNTX) shares have been on a bit of a ride recently, with the latest movement sparking conversations among those watching the biotech space. Investors are weighing the stock’s performance ...
Fintel on MSN
Morgan Stanley Maintains BioNTech SE - Depositary Receipt (BNTX) Overweight Recommendation
Fintel reports that on October 10, 2025, Morgan Stanley maintained coverage of BioNTech SE - Depositary Receipt (NasdaqGS:BNTX) with a Overweight recommendation. Analyst Price Forecast Suggests 33.29% ...
An announcement from BioNTech SE ( ($BNTX) ) is now available. On October 22, 2025, BioNTech SE announced the commencement of a public exchange ...
Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Schwab Fundamental International Large Company Index (Symbol: FNDF) ...
Discover whether Moderna or BioNTech offers better long-term investment potential as both pivot from COVID-19 to innovative ...
Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback